Quadrant Capital Group’s Accendra Health ACH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-751
| Closed | -$1.71K | – | 2148 |
|
|
2026
Q1 | $1.71K | Sell |
751
-2,331
| -76% | -$5.37K | ﹤0.01% | 2527 |
|
|
2025
Q4 | $8.63K | Buy |
3,082
+440
| +17% | +$1.57K | ﹤0.01% | 2243 |
|
|
2025
Q3 | $12.7K | Buy |
+2,642
| New | +$16.8K | ﹤0.01% | 2095 |
|
|
2025
Q2 | – | Sell |
-1,334
| Closed | -$12K | – | 2198 |
|
|
2025
Q1 | $12K | Sell |
1,334
-45
| -3% | -$475 | ﹤0.01% | 2174 |
|
|
2024
Q4 | $18K | Sell |
1,379
-171
| -11% | -$2.28K | ﹤0.01% | 1935 |
|
|
2024
Q3 | $24.3K | Sell |
1,550
-181
| -10% | -$2.74K | ﹤0.01% | 1811 |
|
|
2024
Q2 | $23.4K | Sell |
1,731
-319
| -16% | -$6.53K | ﹤0.01% | 1779 |
|
|
2024
Q1 | $56.8K | Buy |
2,050
+131
| +7% | +$2.91K | ﹤0.01% | 1322 |
|
|
2023
Q4 | $37K | Sell |
1,919
-263
| -12% | -$4.76K | ﹤0.01% | 1542 |
|
|
2023
Q3 | $35.3K | Sell |
2,182
-255
| -10% | -$4.53K | ﹤0.01% | 1434 |
|
|
2023
Q2 | $46.4K | Buy |
2,437
+826
| +51% | +$14.7K | ﹤0.01% | 1299 |
|
|
2023
Q1 | $23.4K | Sell |
1,611
-1,819
| -53% | -$32.6K | ﹤0.01% | 1615 |
|
|
2022
Q4 | $67K | Buy |
3,430
+1,304
| +61% | +$25.4K | 0.01% | 998 |
|
|
2022
Q3 | $51K | Buy |
2,126
+863
| +68% | +$26.6K | 0.01% | 1038 |
|
|
2022
Q2 | $40K | Sell |
1,263
-66
| -5% | -$2.39K | 0.01% | 972 |
|
|
2022
Q1 | $59K | Buy |
1,329
+12
| +0.9% | +$515 | 0.01% | 857 |
|
|
2021
Q4 | $57K | Buy |
1,317
+68
| +5% | +$2.67K | 0.01% | 876 |
|
|
2021
Q3 | $39K | Buy |
1,249
+2
| +0.2% | +$79 | 0.01% | 959 |
|
|
2021
Q2 | $53K | Buy |
1,247
+9
| +0.7% | +$350 | 0.01% | 825 |
|
|
2021
Q1 | $47K | Sell |
1,238
-1,256
| -50% | -$39.3K | 0.01% | 837 |
|
|
2020
Q4 | $67K | Buy |
2,494
+38
| +2% | +$977 | 0.01% | 648 |
|
|
2020
Q3 | $62K | Hold |
2,456
| – | – | 0.01% | 597 |
|
|
2020
Q2 | $19K | Sell |
2,456
-11
| -0.4% | -$81 | ﹤0.01% | 1082 |
|
|
2020
Q1 | $22K | Buy |
2,467
+134
| +6% | +$809 | ﹤0.01% | 1238 |
|
|
2019
Q4 | $12K | Hold |
2,333
| – | – | ﹤0.01% | 1843 |
|
|
2019
Q3 | $13K | Hold |
2,333
| – | – | ﹤0.01% | 1712 |
|
|
2019
Q2 | $7K | Buy |
2,333
+1,917
| +461% | +$6.54K | ﹤0.01% | 1903 |
|
|
2019
Q1 | $0 | Sell |
416
-383
| -48% | -$2.42K | ﹤0.01% | 2308 |
|
|
2018
Q4 | $3K | Buy |
799
+524
| +191% | +$5.44K | ﹤0.01% | 1807 |
|
|
2018
Q3 | $3K | Sell |
275
-95
| -26% | -$1.61K | ﹤0.01% | 1739 |
|
|
2018
Q2 | $4K | Sell |
370
-187
| -34% | -$3.03K | ﹤0.01% | 1652 |
|
|
2018
Q1 | $6K | Sell |
557
-137
| -20% | -$2.44K | ﹤0.01% | 1483 |
|
|
2017
Q4 | $12K | Buy |
694
+632
| +1,019% | +$14K | ﹤0.01% | 1104 |
|
|
2017
Q3 | $1K | Sell |
62
-154
| -71% | -$4.55K | ﹤0.01% | 1998 |
|
|
2017
Q2 | $5K | Buy |
216
+102
| +89% | +$3.35K | ﹤0.01% | 1361 |
|
|
2017
Q1 | $3K | Buy |
114
+89
| +356% | +$3.18K | ﹤0.01% | 1509 |
|
|
2016
Q4 | $0 | Hold |
25
| – | – | ﹤0.01% | 2050 |
|
|
2016
Q3 | $0 | Sell |
25
-173
| -87% | -$6.06K | ﹤0.01% | 2051 |
|
|
2016
Q2 | $7K | Hold |
198
| – | – | ﹤0.01% | 1127 |
|
|
2016
Q1 | $8K | Hold |
198
| – | – | 0.01% | 1041 |
|
|
2015
Q4 | $7K | Hold |
198
| – | – | ﹤0.01% | 923 |
|
|
2015
Q3 | $6K | Buy |
198
+37
| +23% | +$1.26K | ﹤0.01% | 777 |
|
|
2015
Q2 | $5K | Buy |
+161
| New | +$5.42K | ﹤0.01% | 841 |
|
Other funds holding ACH
CCM
ICM
PCMI
Quadrant Capital Group's ACH Position: Q2 2026 in Review
Quadrant Capital Group sold out of Accendra Health (ACH) in Q2 2026, closing a stake of 751 shares — an estimated $1.71K sold.
Quadrant Capital Group first reported a position in ACH in Q2 2015 and held it in 43 quarters. The position peaked at $67K in Q4 2020. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.
- Quadrant Capital Group reported no remaining Accendra Health position as of Q2 2026 after selling out during the quarter.
- Quadrant Capital Group sold 751 Accendra Health shares in Q2 2026, an estimated $1.71K.
- Quadrant Capital Group first reported a position in Accendra Health in Q2 2015 and held it in 43 quarters.
- Quadrant Capital Group's Accendra Health position peaked at $67K in Q4 2020.
- 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.
Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.